Company intelligence / Profile preview

Zhejiang Boye Biotech

Huzhou, Zhejiang, Chinadnb.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Zhejiang Boye Biotech is a private Chinese life sciences/biotechnology company founded in 2021, based in Huzhou, Zhejiang province. The company appears to be early-stage with no publicly disclosed drug candidates or clinical results as of January 2025. It is active in the healthcare and biotech sector and has engaged in international licensing deals through subsidiaries.

Industry: Investors

Partnerships

Edinburgh Biosciences Ltd. (“EBS”): Licensing and equity investment deal via Haoguang Bio-tech subsidiary for cataract treatment technology using LED light devices targeting China market

Beyond the preview

Go deeper on Zhejiang Boye Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Boye Biotech.

Explore the full profile